Kate Broderick, PhD, molecular geneticist, discusses the mRNA capping technology and how it helps create stability to mRNA molecules within vaccines and guides them to cells.
Kate Broderick, PhD
Advertisement
Broderick is chief innovation officer at Maravai LifeSciences.
Articles by Kate Broderick, PhD
Advertisement
Latest Updated Articles
mRNA Capping: A Component That Protects the COVID-19 Vaccine and Lends to its EffectivenessPublished: August 11th 2024 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance
2
As NDM-CRE Infections Rise Significantly, Diagnostic Access Emerges as Weak Link
3
Emerging Diagnostic Tools and Mycobacterial Challenges in Skin and Soft Tissue Infections
4
Misdiagnosis Common in Skin Infections Due to Overlapping Noninfectious Conditions
5
